1,720,955 research outputs found
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Full text link“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Full text linkWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Connecting the lines between hypogonadism and atherosclerosis
No full textEpidemiological studies show that atherosclerotic cardiovascular disease is a leading cause of morbidity and mortality worldwide and point to gender differences with ageing males being at highest risk. Atherosclerosis is a complex process that has several risk factors and mediators. Hypogonadism is a commonly undiagnosed disease that has been associated with many of the events, and risk factors leading to atherosclerosis. The mechanistic relations between testosterone levels, atherosclerotic events, and risk factors are poorly understood in many instances, but the links are clear. In this paper, we summarize the research journey that explains the link between hypogonadism, each of the atherosclerotic events, and risk factors. We look into the different areas from which lessons could be learned, including epidemiological studies, animal and laboratory experiments, studies on androgen deprivation therapy patients, and studies on testosterone-treated patients. We finish by providing recommendations for the clinician and needs for future research. Copyright © 2012 Akl C. Fahed et al.Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161-ATVBAHA.107.160192; Akishita M, 2007, HYPERTENS RES, V30, P1029, DOI 10.1291-hypres.30.1029; Alexandersen P, 1999, CIRC RES, V84, P813; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056-NEJMoa001066; Aversa A, 2010, J SEX MED, V7, P3495, DOI 10.1111-j.1743-6109.2010.01931.x; BARRETTCONNOR E, 1992, ANN INTERN MED, V117, P807; Basaria S, 2010, J CLIN ENDOCR METAB, V95, P1533, DOI 10.1210-jc.2009-1579; Bhatia V, 2006, DIABETES CARE, V29, P2289, DOI 10.2337-dc06-0637; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056-NEJM199707313370502; Bourghardt J, 2010, ENDOCRINOLOGY, V151, P5428, DOI 10.1210-en.2010-0663; Boyanov M A, 2003, Aging Male, V6, P1; Brown-Sequard C., 1889, LANCET, V134, P105; Cakir E, 2005, J CLIN ENDOCR METAB, V90, P1651, DOI 10.1210-jc.2004-2045; Calof OM, 2005, J GERONTOL A-BIOL, V60, P1451; Caminiti G, 2009, J AM COLL CARDIOL, V54, P919, DOI 10.1016-j.jacc.2009.04.078; Choong K, 2010, AGING MALE, V13, P1, DOI 10.3109-13685530903410625; Cornoldi A, 2010, INT J CARDIOL, V142, P50, DOI 10.1016-j.ijcard.2008.12.107; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056-NEJMoa0804381; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001-jama.295.11.1288; Ezaki K, 2010, CIRC J, V74, P2448, DOI 10.1253-circj.CJ-10-0221; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210-jc.2009-2575; Foresta C, 2006, J CLIN ENDOCR METAB, V91, P4599, DOI 10.1210-jc.2006-0763; Foresta C, 2008, CLIN ENDOCRINOL, V68, P284, DOI 10.1111-j.1365-2265.2007.03036.x; Freeman ER, 2001, J UROLOGY, V165, P371, DOI 10.1097-00005392-200102000-00004; Fu L, 2008, ASIAN J ANDROL, V10, P214, DOI 10.1111-j.1745-7262.2008.00335.x; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161-ATVBAHA.107.147835; Haddad RM, 2007, MAYO CLIN PROC, V82, P29; HAFFNER SM, 1993, J CLIN ENDOCR METAB, V77, P1610, DOI 10.1210-jc.77.6.1610; Haidar A, 2007, AGING MALE, V10, P189, DOI 10.1080-13685530701653538; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210-jc.87.8.3632; Hanke H, 2001, CIRCULATION, V103, P1382; Hatakeyama H, 2002, FEBS LETT, V530, P129, DOI 10.1016-S0014-5793(02)03440-3; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161-hc4601.099485; Heufelder AE, 2009, J ANDROL, V30, P726, DOI 10.2164-jandrol.108.007005; Hougaku H, 2006, AM J PHYSIOL-ENDOC M, V290, pE234, DOI 10.1152-ajpendo.00059.2005; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111-j.1365-2265.2005.02339.x; JAFFE MD, 1977, BRIT HEART J, V39, P1217; Johnsen SH, 2005, CIRCULATION, V112, P498, DOI 10.1161-CIRCULATIONAHA.104.522706; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337-dc10-1233; Jones TH, 2009, ATHEROSCLEROSIS, V207, P318, DOI 10.1016-j.atherosclerosis.2009.04.016; Kalinchenko SY, 2010, CLIN ENDOCRINOL, V73, P602, DOI 10.1111-j.1365-2265.2010.03845.x; Kang SM, 2002, AM J CARDIOL, V89, P862, DOI 10.1016-S0002-9149(02)02202-6; Kaplan SA, 2010, AGING MALE, V13, P40, DOI 10.3109-13685530903536676; Kapoor D, 2007, EUR J ENDOCRINOL, V156, P595, DOI 10.1530-EJE-06-0737; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530-eje.1.02166; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200-JCO.2006.06.2497; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM460; Keymel S, 2008, BASIC RES CARDIOL, V103, P582, DOI 10.1007-s00395-008-0742-z; Kumanov P, 2007, INT J ANDROL, V30, P41, DOI 10.1111-j.1365-2605.2006.00706.x; Kumanov P, 2002, ANDROLOGIA, V34, P29, DOI 10.1046-j.1439-0272.2002.00468.x; Laaksonen DE, 2005, J CLIN ENDOCR METAB, V90, P712, DOI 10.1210-jc.2004-0970; Laaksonen DE, 2003, EUR J ENDOCRINOL, V149, P601, DOI 10.1530-eje.0.1490601; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337-diacare.27.5.1036; Leifke E, 2008, HORM METAB RES, V40, P56, DOI 10.1055-s-2007-1004529; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016-0002-8703(86)90155-9; Lesser MA, 1942, NEW ENGL J MED, V226, P51, DOI 10.1056-NEJM194201082260203; LESSER MA, 1946, J CLIN ENDOCR METAB, V6, P549; Ling SH, 2002, ENDOCRINOLOGY, V143, P1119, DOI 10.1210-en.143.3.1119; Liva SM, 2001, J IMMUNOL, V167, P2060; Ly LP, 2001, J CLIN ENDOCR METAB, V86, P4078, DOI 10.1210-jc.86.9.4078; Malkin CJ, 2010, CURR OPIN ENDOCRINOL, V17, P262, DOI 10.1097-MED.0b013e328339543e; Malkin CJ, 2004, J CLIN ENDOCR METAB, V89, P3313, DOI 10.1210-jc.2003-031069; Maravelias C, 2005, TOXICOL LETT, V158, P167, DOI 10.1016-j.toxlet.2005.06.005; Mårin P, 1993, Obes Res, V1, P245; Marin R, 1999, BIOL REPROD, V61, P1012, DOI 10.1095-biolreprod61.4.1012; Mathur A, 2009, EUR J ENDOCRINOL, V161, P443, DOI 10.1530-EJE-09-0092; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161-CIRCULATIONAHA.105.555235; McCrohon JA, 2000, CIRCULATION, V101, P224; Mercuro G, 2010, J CARDIOVASC MED, V11, P207, DOI 10.2459-JCM.0b013e32833178ed; Morimoto S, 2005, J ENDOCRINOL, V187, P217, DOI 10.1677-joe.1.06357; Muller M, 2005, J CLIN ENDOCR METAB, V90, P2618, DOI 10.1210-jc.2004-1158; Muller M, 2004, CIRCULATION, V109, P2074, DOI 10.1161-01.CIR.0000125854.51637.06; Naharci Mehmet Ilkin, 2007, Endocr Pract, V13, P629; Nettleship JE, 2007, CIRCULATION, V116, P2427, DOI 10.1161-CIRCULATIONAHA.107.708768; Ng MKC, 2002, ARTERIOSCL THROM VAS, V22, P1136, DOI 10.1161-01.ATV.0000022167.80130.A6; Niskanen L, 2004, DIABETES OBES METAB, V6, P208, DOI 10.1111-j.1462-8902.2004.00335.x; Pearson LJ, 2008, PEPTIDES, V29, P1057, DOI 10.1016-j.peptides.2008.02.003; Pritchard J, 1998, J CLIN ENDOCR METAB, V83, P3277, DOI 10.1210-jc.83.9.3277; Qiu Y, 2010, ENDOCRINOLOGY, V151, P3307, DOI 10.1210-en.2009-1268; Rajala Ulla M, 2007, Diabetes Care, V30, pe13, DOI 10.2337-dc06-1979; Saad F, 2011, J OBES; Schroeder ET, 2004, J CLIN ENDOCR METAB, V89, P4863, DOI 10.1210-jc.2004-0784; Schwartz BG, 2009, INT J IMPOT RES, V21, P327, DOI 10.1038-ijir.2009.38; Selvin E, 2007, DIABETES CARE, V30, P234, DOI 10.2337-dc06-1579; Shabsigh R, 2009, INT J IMPOT RES, V21, P9, DOI 10.1038-ijir.2008.31; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002-cncr.20955; Simon D, 1997, J CLIN ENDOCR METAB, V82, P682, DOI 10.1210-jc.82.2.682; Smith Matthew R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P247, DOI 10.1097-MED.0b013e32814db88c; Svartberg J, 2004, EUR J ENDOCRINOL, V150, P65, DOI 10.1530-eje.0.1500065; WU SZ, 1993, CHINESE MED J-PEKING, V106, P415; TENOVER JS, 1992, J CLIN ENDOCR METAB, V75, P1092, DOI 10.1210-jc.75.4.1092; Tharp DL, 2009, CARDIOVASC RES, V82, P152, DOI 10.1093-cvr-cvp038; THOMPSON PD, 1989, JAMA-J AM MED ASSOC, V261, P1165, DOI 10.1001-jama.261.8.1165; Tomaszewski M, 2009, ATHEROSCLEROSIS, V203, P257, DOI 10.1016-j.atherosclerosis.2008.06.002; Traish AM, 2009, VASC PHARMACOL, V51, P303, DOI 10.1016-j.vph.2009.09.003; Traish AM, 2009, FEBS J, V276, P5755, DOI 10.1111-j.1742-4658.2009.07305.x; Traish AM, 2009, J ANDROL, V30, P23, DOI 10.2164-jandrol.108.005751; Uyanik BS, 1997, JPN HEART J, V38, P73; Van Pottelbergh I, 2003, ATHEROSCLEROSIS, V166, P95, DOI 10.1016-S0021-9150(02)00308-8; Vignozzi L, 2007, J SEX MED, V4, P620, DOI 10.1111-j.1743-6109.2007.00440.x; Walker TC, 1942, J CLIN ENDOCRINOL, V2, P560; WHO, 2011, GLOB STAT REP NONC D; Yeap BB, 2010, CURR OPIN ENDOCRINOL, V17, P269, DOI 10.1097-MED.0b013e3283383031; Zgliczynski S, 1996, ATHEROSCLEROSIS, V121, P35, DOI 10.1016-0021-9150(95)05673-4; Zitzmann M, 2007, J CLIN ENDOCR METAB, V92, P3844, DOI 10.1210-jc.2007-0620; Zitzmann M, 2008, J ANDROL, P54; Zitzmann M, 2002, J CLIN ENDOCR METAB, V87, P5030, DOI 10.1210-jc.2002-020504; Zumoff B, 2003, METABOLISM, V52, P1126, DOI 10.1016-S0026-0495(03)00186-078
Dispelling the Myths Behind First-author Citation Counts
Full text linkWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
koamabayili/VECTRON-author-checklist: VECTRON author checklist
No full textWe have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
Author-wise bibliometric analysis based on entropy.
No full textAuthor-wise bibliometric analysis based on entropy.</p
Author Under Sail The Imagination of Jack London, 1893-1902
No full textIn Author Under Sail, Jay Williams offers the first complete literary biography of Jack London as a professional writer engaged in the labor of writing. It examines the authorial imagination in London's work, the use of imagination in both his fiction and nonfiction, and the ways he defined imagination in the creative process in his business dealings with his publishers, editors, and agents. In this first volume of a two-volume biography, Williams traverses the years 1893 to 1902, from London's "Story of a Typhoon" to The People of the Abyss. The Jack London who emerges in the pages of Author Under Sail is a writer whose partnership with publishers, most notably his productive alliance with George Brett of Macmillan, was one of the most formative in American literary history. London pioneered many author models during the heyday of realism and naturalism, blurring the boundaries of these popular genres by focusing on absorption and theatricality and the representation of the seen and unseen. London created an impassioned, sincere, and extremely personal realism unlike that of other American writers of the time. Author Under Sail is a literary tour de force that reveals the full range of London as writer, creative citizen, and entrepreneur at the same time it sheds light on the maverick side of machine-age literature.Intro -- Title Page -- Copyright Page -- Dedication -- Contents -- Acknowledgments -- Introduction -- 1. Spirit Truth -- 2. From Absorption to Theatricality and Back Again -- 3. "I Will Build a New Present" -- 4. Sons as Authors -- 5. Fathers as Publishers -- 6. The Daughter as Author -- 7. Lovers as Authors -- 8. At Sea with the Family -- 9. Yellow News, Yellow Stories -- 10. The Return Home -- Notes -- Bibliography -- Index -- About Jay WilliamsIn Author Under Sail, Jay Williams offers the first complete literary biography of Jack London as a professional writer engaged in the labor of writing. It examines the authorial imagination in London's work, the use of imagination in both his fiction and nonfiction, and the ways he defined imagination in the creative process in his business dealings with his publishers, editors, and agents. In this first volume of a two-volume biography, Williams traverses the years 1893 to 1902, from London's "Story of a Typhoon" to The People of the Abyss. The Jack London who emerges in the pages of Author Under Sail is a writer whose partnership with publishers, most notably his productive alliance with George Brett of Macmillan, was one of the most formative in American literary history. London pioneered many author models during the heyday of realism and naturalism, blurring the boundaries of these popular genres by focusing on absorption and theatricality and the representation of the seen and unseen. London created an impassioned, sincere, and extremely personal realism unlike that of other American writers of the time. Author Under Sail is a literary tour de force that reveals the full range of London as writer, creative citizen, and entrepreneur at the same time it sheds light on the maverick side of machine-age literature.Description based on publisher supplied metadata and other sources.Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, YYYY. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries
- …
